BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Oxford BioTherapeutics 

94a Milton Park

Abingdon  Oxon  OX14 4RY  United Kingdom
Phone: 44-0-1235-861770 Fax: 44-0-1235-861771


SEARCH JOBS




Industry
Biotechnology






 Company News
Oxford BioTherapeutics Appoints Dr. Eugen Leo As Head Of Clinical Development 7/8/2014 10:44:07 AM
Oxford BioTherapeutics Appoints Dr Keith E Wilson As Chief Scientific Officer 6/18/2014 9:26:37 AM
Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD To Its Board Of Directors 1/15/2014 8:00:19 AM
Oxford BioTherapeutics And Menarini Group Progress Enhanced Antibody For Acute Myeloid Leukemia As First Clinical Development Candidate In $1 Billion Oncology Investment Alliance 12/9/2013 7:57:38 AM
Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman 6/26/2013 6:26:13 AM
Oxford BioTherapeutics and Boehringer Ingelheim Corporation Enter Collaboration to Discover Novel Antibody Targets in Cancer 4/29/2013 9:49:15 AM
Menarini, Oxford BioTherapeutics Ink $1 Billion Cancer Pact; Partnership Will Develop Five Antibody-Based Anticancer Drugs 10/29/2012 9:50:05 AM
Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland 5/2/2012 10:35:47 AM
Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director 1/11/2012 2:12:28 PM
Seattle Genetics, Inc. (SGEN) and Oxford BioTherapeutics to Collaborate on Antibody-Drug Conjugates for Cancer 9/13/2011 10:37:42 AM
12